Sex Differences in Recovery-Related Outcomes and Needs for Psychiatric Rehabilitation in People With Schizophrenia Spectrum Disorder

References (67)

1. Seeman MV. Does gender influence outcome in schizophrenia? Psychiatr Q. 2019;90(1):173–184. PubMed CrossRef
2. Leamy M, Bird V, Le Boutillier C, et al. Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry. 2011;199(6):445–452. PubMed CrossRef
3. Leonhardt BL, Huling K, Hamm JA, et al. Recovery and serious mental illness: a review of current clinical and research paradigms and future directions. Expert Rev Neurother. 2017;17(11):1117–1130. PubMed CrossRef
4. Albert N, Bertelsen M, Thorup A, et al. Predictors of recovery from psychosis Analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years. Schizophr Res. 2011;125(2–3):257–266. PubMed CrossRef
5. Álvarez-Jiménez M, Gleeson JF, Henry LP, et al. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years. Psychol Med. 2012;42(3):595–606. PubMed CrossRef
6. Jääskeläinen E, Juola P, Hirvonen N, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39(6):1296–1306. PubMed CrossRef
7. Thorup A, Albert N, Bertelsen M, et al. Gender differences in first-episode psychosis at 5-year follow-up–two different courses of disease? Results from the OPUS study at 5-year follow-up. Eur Psychiatry. 2014;29(1):44–51. PubMed CrossRef
8. Seeman MV, Gupta R. Selective review of age-related needs of women with schizophrenia. Clin Schizophr Relat Psychoses. 2015;9(1):21–29. PubMed CrossRef
9. Arvidsson H. Gender differences in needs and care of severely mentally ill persons: findings from a Swedish cross-sectional and longitudinal study. Int J Soc Psychiatry. 2010;56(4):424–435. PubMed CrossRef
10. Mancuso SG, Morgan VA, Mitchell PB, et al. A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: results from the Second Australian National Psychosis Survey. J Affect Disord. 2015;172:30–37. PubMed CrossRef
11. Comacchio C, Howard LM, Bonetto C, et al; GET UP Group. The impact of gender and childhood abuse on age of psychosis onset, psychopathology and needs for care in psychosis patients. Schizophr Res. 2019;210:164–171. PubMed CrossRef
12. Bertani M, Lasalvia A, Bonetto C, et al. The influence of gender on clinical and social characteristics of patients at psychosis onset: a report from the Psychosis Incident Cohort Outcome Study (PICOS). Published correction appears in Psychol Med. 2012 Apr;42(4). Psychol Med. 2012;42(4):769–780. PubMed CrossRef
13. Ho RWH, Chang WC, Kwong VWY, et al. Prediction of self-stigma in early psychosis: 3-Year follow-up of the randomized-controlled trial on extended early intervention. Schizophr Res. 2018;195:463–468. PubMed CrossRef
14. Song LY. Predictors of personal recovery for persons with psychiatric disabilities: an examination of the Unity Model of Recovery. Psychiatry Res. 2017;250:185–192. PubMed CrossRef
15. Caqueo-Urízar A, Fond G, Urzúa A, et al. Gender differences in schizophrenia: a multicentric study from three Latin-America countries. Psychiatry Res. 2018;266:65–71. PubMed CrossRef
16. Mayston R, Kebede D, Fekadu A, et al. The effect of gender on the long-term course and outcome of schizophrenia in rural Ethiopia: a population-based cohort. Soc Psychiatry Psychiatr Epidemiol. 2020;55(12):1581–1591. PubMed CrossRef
17. Carpiniello B, Pinna F, Tusconi M, et al. Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study. Schizophr Res Treatment. 2012;2012:576369. PubMed CrossRef
18. Franck N, Bon L, Dekerle M, et al. Satisfaction and needs in serious mental illness and autism spectrum disorder: The REHABase Psychosocial Rehabilitation Project. Psychiatr Serv. 2019;70(4):316–323. PubMed CrossRef
19. Dubreucq J, Plasse J, Gabayet F, et al; REHABAse Network. Self-stigma in serious mental illness and autism spectrum disorder: results from the REHABase national psychiatric rehabilitation cohort. Eur Psychiatry. 2020;63(1):e13. PubMed CrossRef
20. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2013 National Survey on Drug Use and Health: Mental Health Findings. NSDUH Series H-49, HHS Publication No. (SMA) 14-4887. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
21. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. Fifth Edition. Washington, DC: American Psychiatric Press; 2013.
22. Startup M, Jackson MC, Bendix S. The concurrent validity of the Global Assessment of Functioning (GAF). Br J Clin Psychol. 2002;41(Pt 4):417–422. PubMed CrossRef
23. Andresen R, Caputi P, Oades L. Stages of recovery instrument: development of a measure of recovery from serious mental illness. Aust N Z J Psychiatry. 2006;40(11-12):972–980. PubMed CrossRef
24. Haro JM, Kamath SA, Ochoa S, et al; SOHO Study Group. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand suppl. 2003;107(416):16–23. PubMed CrossRef
25. Birchwood M, Smith J, Drury V, et al. A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand. 1994;89(1):62–67. PubMed CrossRef
26. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42(3):241–247. PubMed CrossRef
27. Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res. 2003;121(1):31–49. PubMed CrossRef
28. Lecomte T, Corbière M, Laisné F. Investigating self-esteem in individuals with schizophrenia: relevance of the Self-Esteem Rating Scale-Short Form. Psychiatry Res. 2006;143(1):99–108. PubMed CrossRef
29. Wallace CJ, Lecomte T, Wilde J, et al. CASIG: a consumer-centered assessment for planning individualized treatment and evaluating program outcomes. Schizophr Res. 2001;50(1–2):105–119. PubMed CrossRef
30. Auquier P, Simeoni MC, Sapin C, et al. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr Res. 2003;63(1–2):137–149. PubMed CrossRef
31. Tennant R, Hiller L, Fishwick R, et al. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5(1):63. PubMed CrossRef
32. Wechsler D. WAIS IV Nouvelle version de l’échelle d’intelligence de Weschler pour adultes. 4th ed. Paris, France: Edition de Centre de Psychologie Appliquée; 2008.
33. Deweer B, Poitrenaud J, Kalafat M, et al. Manuel du California Verbal Learning Test. Paris, France: les Editions du Centre de Psychologie Appliquée; 2008.
34. Van der Linden M, Coyette F, Poitrenaud J, et al. L’épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). In: Van der Linden M, Adam S, Ag-niel A, et Membres du GRENEM, Eds. L’évaluation des troubles de la mémoire: présentation de quatre tests de mémoire épisodique avec leur étalonnage. 2004; Marseille, France: Sola; 25–47.
35. Brickenkamp R, Schmidt-Atzert L, Liepmann D. D2-R: Test d’attention concentrée révisée. Paris, France: Editions Hogrefe; 2015.
36. Fournet N, Demazières-Pelletier Y, Favier S, et al. Test des commissions révisé. GREMOIRE II Tests et échelles des maladies neurologiques avec symptomatologie cognitive. Paris, France: De Boeck-Solal; 2015.
37. Shallice T, Burgess PW. Deficits in strategy application following frontal lobe damage in man. Brain. 1991;114(pt 2):727–741. PubMed CrossRef
38. Dziobek I, Fleck S, Kalbe E, et al. Introducing MASC: a movie for the assessment of social cognition. J Autism Dev Disord. 2006;36(5):623–636. PubMed CrossRef
39. Combs DR, Penn DL, Wicher M, et al. The Ambiguous Intentions Hostility Questionnaire (AIHQ): a new measure for evaluating hostile social-cognitive biases in paranoia. Cogn Neuropsychiatry. 2007;12(2):128–143. PubMed CrossRef
40. R Core Team. R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. 2015. https://www.R-project.org/
41. Kuehner C. Why is depression more common among women than among men? Lancet Psychiatry. 2017;4(2):146–158. PubMed CrossRef
42. Li SH, Graham BM. Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? the potential role of sex hormones. Lancet Psychiatry. 2017;4(1):73–82. PubMed CrossRef
43. Miranda-Mendizabal A, Castellví P, Parés-Badell O, et al. Gender differences in suicidal behavior in adolescents and young adults: systematic review and meta-analysis of longitudinal studies. Int J Public Health. 2019;64(2):265–283. PubMed CrossRef
44. Tew J, Ramon S, Slade M, et al. Social factors and recovery from mental health difficulties: a review of the evidence. Br J Soc Work. 2012;42(3):443–460. CrossRef
45. Firmin RL, Zalzala AB, Hamm JA, et al. How psychosis interrupts the lives of women and men differently: a qualitative comparison [published online ahead of print November 20, 2020]. Psychol Psychother. 2020. PubMed
46. Haarmans M, McKenzie K, Kidd SA, et al. Gender role strain, core schemas, and psychotic experiences in ethnically diverse women: a role for sex- and gender-based analysis in psychosis research? Clin Psychol Psychother. 2018;25(6):774–784. PubMed CrossRef
47. García-Mieres H, Montesano A, Villaplana A, et al. Common and differential dimensions of personal identity between psychosis and depression: The relevance of gender and depressive mood. J Psychiatr Res. 2020;127:48–56. PubMed CrossRef
48. Lysaker PH, Pattison ML, Leonhardt BL, et al. Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments. World Psychiatry. 2018;17(1):12–23. PubMed CrossRef
49. Badcock JC, Di Prinzio P, Waterreus A, et al. Loneliness and its association with health service utilization in people with a psychotic disorder. Schizophr Res. 2020;223:105–111. PubMed CrossRef
50. Hanlon MC, Campbell LE, Single N, et al. Men and women with psychosis and the impact of illness-duration on sex-differences: the second Australian national survey of psychosis. Psychiatry Res. 2017;256:130–143. PubMed CrossRef
51. Farrelly S, Clement S, Gabbidon J, et al; MIRIAD study group. Anticipated and experienced discrimination amongst people with schizophrenia, bipolar disorder and major depressive disorder: a cross sectional study. BMC Psychiatry. 2014;14(1):157. PubMed CrossRef
52. Pellet J, Golay P, Nguyen A, et al. The relationship between self-stigma and depression among people with schizophrenia-spectrum disorders: a longitudinal study. Psychiatry Res. 2019;275:115–119. PubMed CrossRef
53. Jeffery D, Clement S, Corker E, et al. Discrimination in relation to parenthood reported by community psychiatric service users in the UK: a framework analysis. BMC Psychiatry. 2013;13(1):120. PubMed CrossRef
54. Lacey M, Paolini S, Hanlon MC, et al. Parents with serious mental illness: differences in internalised and externalised mental illness stigma and gender stigma between mothers and fathers. Psychiatry Res. 2015;225(3):723–733. PubMed CrossRef
55. Lappin JM, Heslin M, Lomas B, et al. Early sustained recovery following first episode psychosis: evidence from the AESOP10 follow-up study. Schizophr Res. 2018;199:341–345. PubMed CrossRef
56. Villeneuve K, Potvin S, Lesage A, et al. Meta-analysis of rates of drop-out from psychosocial treatment among persons with schizophrenia spectrum disorder. Schizophr Res. 2010;121(1-3):266–270. PubMed CrossRef
57. Charlson FJ, Ferrari AJ, Santomauro DF, et al. Global epidemiology and burden of schizophrenia: findings from the Global Burden of Disease Study 2016. Schizophr Bull. 2018;44(6):1195–1203. PubMed CrossRef
58. Dubreucq J, Ycart B, Gabayet F, et al; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Towards an improved access to psychiatric rehabilitation: availability and effectiveness at 1-year follow-up of psychoeducation, cognitive remediation therapy, cognitive behaviour therapy and social skills training in the FondaMental Advanced Centers of Expertise-Schizophrenia (FACE-SZ) national cohort. Eur Arch Psychiatry Clin Neurosci. 2019;269(5):599–610. PubMed CrossRef
59. Ferrari M, Flora N, Anderson KK, et al; ACE Project Team. Gender differences in pathways to care for early psychosis. Early Interv Psychiatry. 2018;12(3):355–361. PubMed CrossRef
60. Fond G, Boyer L, Leboyer M, et al; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Influence of Venus and Mars in the cognitive sky of schizophrenia: results from the first-step national FACE-SZ cohort. Schizophr Res. 2018;195:357–365. PubMed CrossRef
61. Li AWY, Hui CLM, Lee EHM, et al. Gender differences in correlates of cognition in first-episode psychosis. Psychiatry Res. 2019;271:412–420. PubMed CrossRef
62. Revier CJ, Reininghaus U, Dutta R, et al. Ten-year outcomes of first-episode psychoses in the MRCÆSOP-10 Study. J Nerv Ment Dis. 2015;203(5):379–386. PubMed CrossRef
63. Austin SF, Mors O, Secher RG, et al. Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up. Schizophr Res. 2013;150(1):163–168. PubMed CrossRef
64. Hache-Labelle C, Abdel-Baki A, Lepage M, et al. Romantic relationship group intervention for men with early psychosis: a feasibility, acceptability and potential impact pilot study [published online ahead of print June 23, 2020]. Early Interv Psychiatry. 2020. PubMed CrossRef
65. Müller AD, Gjøde ICT, Eigil MS, et al. VIA Family—a family-based early intervention versus treatment as usual for familial high-risk children: a study protocol for a randomized clinical trial. Trials. 2019;20(1):112. PubMed CrossRef
66. Lysaker PH, Dimaggio G. Metacognitive capacities for reflection in schizophrenia: implications for developing treatments. Schizophr Bull. 2014;40(3):487–491. PubMed CrossRef
67. de Jong S, van Donkersgoed RJM, Timmerman ME, et al. Metacognitive reflection and insight therapy (MERIT) for patients with schizophrenia. Psychol Med. 2019;49(2):303–313. PubMed CrossRef